HR Execs on the Move

Echo Therapeutics

www.echotx.com

 
Echo Therapeutics is developing its Symphony CGM System as a non-invasive, wireless, continuous glucose monitoring system. A significant consumer (non-regulated) opportunity also exists for Symphony to be used in the fitness, weight loss and personal lifestyle space. Echo also developed its needle-free skin preparation device as a platform technology that allowed for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.echotx.com
  • 99 Wood Avenue South Suite 302
    Iselin, NJ USA 08830
  • Phone: 508.553.8850

Executives

Name Title Contact Details

Similar Companies

Inotech Biosystems

Inotech Biosystems is a Derwood, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

University Medical Center of Southern Nevada

University Medical Center of Southern Nevada is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Las Vegas, NV. To find more information about University Medical Center of Southern Nevada, please visit www.umcsn.com

inVentiv Medical Management

inVentiv Medical Management is a Augusta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HASTINGS and PRINCE ED CNTY HLTH

HASTINGS & PRINCE ED CNTY HLTH is a Belleville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Heart Force Medical

Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.